Brinton Pharmaceuticals - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2014, Brinton Pharmaceuticals operates in Health Tech offering safe, economical and innovative medical solutions to meet the lifelong demands of people. The company is committed to supporti...
Funding stage:
Debt Financing
Last funding:
15/09/2020
Total funding:
$13.36 Mn+
Revenue:
Investors
Employee count:
735
Last 90d
735
Last 90d
Web traffic:
18.44K
18.44K
Last 30d
Last 30d
Glassdoor Rating:
Brinton Pharmaceuticals: Funding Highlights
Funding highlights of Brinton Pharmaceuticals and a snapshot of its key metrics.
Total Funding$13.36 Mn+
Current StageGrowth Stage
Total Round(s)3
Funding Rounds
FAQs on Funding of Brinton Pharmaceuticals
Health Tech Funded Brinton Pharmaceuticals has raised a total funding of $13.36 million as of 16 September 2020 across 3 rounds. Find the details around funding rounds, participating investors, and other insights of Brinton Pharmaceuticals here...
Brinton Pharmaceuticals has raised a total of $13.36 million across 3 funding rounds and the last round was raised on 16 September 2020.
Brinton Pharmaceuticals's key investors include BlackSoil, India Alternatives Private Equity Fund, and Tata Capital.
Brinton Pharmaceuticals's latest funding round was $1.36 million in Growth Stage, raised on 16 September 2020.
Brinton Pharmaceuticals is at the Growth stage. Its most recent round was raised on 16 September 2020.
Brinton Pharmaceuticals's last known valuation was $44.34 million as of 15 June 2019.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links